Noticias de AKTX_US

Noticias del mercado

Últimas noticias sobre AKTX_US — 209 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AKTX_US ✕ 209 resultados
12/05/2026 AKTX_US — Investing.com
Akari Therapeutics secures European patent for ADC payload By Investing.com
12/05/2026 AKTX_US — Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12/05/2026 AKTX_US — Investing.com
Akari Therapeutics secures European patent for ADC payload By Investing.com
12/05/2026 AKTX_US — GuruFocus
Akari Therapeutics (AKTX) Secures Key European Patent for Innova
12/05/2026 AKTX_US — GlobeNewswire
Akari Therapeutics Secures Key European Patent For Its
12/05/2026 AKTX_US — The Manila Times
Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets
12/05/2026 AKTX_US — Quiver Quantitative
Akari Therapeutics Strengthens Global IP Position with Major European Patent Grant for Thailanstatin Analogs in ADC Therapies
08/05/2026 AKTX_US — Stock Titan
Akari Therapeutics (NASDAQ: AKTX) plans ADS and complex warrant sale
05/05/2026 AKTX_US — newsline.com
The moat Akari (AKTX) is building for long term dominance (-7.18%) 2026-05-05 - Corrective Wave
05/05/2026 AKTX_US — newsline.com
The moat Akari (AKTX) is building for long term dominance (-7.18%) 2026-05-05 - NHNL Divergence
05/05/2026 AKTX_US — The Legal Advocate
The moat Akari (AKTX) is building for long term dominance (-7.18%) 2026-05-05 - Advance Decline Line
01/05/2026 AKTX_US — Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Akanda (NASDAQ:AKAN), Akari Therapeutics (N
27/04/2026 AKTX_US — Yahoo Finance
Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload
27/04/2026 AKTX_US — Stock Titan
Akari adds Australian patent cover for payload behind two cancer programs
27/04/2026 AKTX_US — Investing.com
Akari Therapeutics secures Australian patent for ADC payload
27/04/2026 AKTX_US — GuruFocus
Akari Therapeutics (AKTX) Secures Key Australian Patent for ADC Technology
27/04/2026 AKTX_US — The Manila Times
Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload
27/04/2026 AKTX_US — GlobeNewswire
Akari Therapeutics Secures Australian Patent Approval,
21/04/2026 AKTX_US — Stock Titan
Akari wins first ASCO slot with AKTX-101 data in KRAS tumors
21/04/2026 AKTX_US — Yahoo Finance
Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors

Página 10 de 11

keyboard_arrow_up